https://www.selleckchem.com/products/azd9291.html
This review focuses on the neural mechanisms relevant to AF and the recent developments of neuromodulation methods for AF control.The treatment of drug-refractory chronic ventricular tachycardia (VT) has undergone a revolution over the last 50 years. We now have automatic implantable cardioverter defibrillator therapy with pace-terminating capabilities, and catheter ablation of VT has refined mapping and improved methods of lesion generation. Between 1980 and 1993, Houston Methodist Hospital became a leader in the diagnosis and surgical